Rescheduling marijuana to Schedule III marks a pivotal shift in federal drug policy by acknowledging its accepted medical use and moderate to low potential for dependence. This change promises tax relief, streamlined research, improved banking access, and clearer regulatory pathways for medical marijuana under the Controlled Substances Act. The rescheduling process involves scientific review, rulemaking, […]